Phase II trial of docetaxel and topotecan in recurrent and extensive small cell lung cancer

被引：0
|
作者：
Gormley, N
Edelman, MJ
Smith, R
Hausner, PF
Bedor, M
Bisaccia, S
机构：
[1] Univ Maryland, Greenebraum Canc Ctr, Baltimore, MD 21201 USA
[2] VA Maryland Hlth Care Syst, Baltimore, MD USA
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [21] Phase II Trial of Consolidation Chest Radiotherapy for Extensive Stage Small Cell Lung Cancer
    Yee, D.
    Butts, C.
    Chu, Q.
    Fenton, D.
    Joy, A.
    Reiman, A.
    Smylie, M.
    Roa, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S527 - S527
  • [22] Topotecan in the treatment of recurrent small-cell lung cancer
    Denisso, Tadeusz
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (03): : 99 - 104
  • [23] Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
    Reck, M
    Groth, G
    Buchholz, E
    Goetz, E
    Gatzemeier, U
    Manegold, C
    LUNG CANCER, 2005, 48 (03) : 409 - 413
  • [24] Topotecan in the treatment of recurrent small cell lung cancer: An update
    Ardizzoni, A
    ONCOLOGIST, 2004, 9 : 4 - 13
  • [25] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [26] Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Miller, VA
    Krug, LM
    Ng, KK
    Pizzo, B
    Perez, W
    Heelan, RT
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1346 - 1350
  • [27] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [28] Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC).
    Chen, Y
    Zhao, Y
    Chen, Z
    Liao, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 708S - 708S
  • [29] PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER
    FOSSELLA, FV
    LEE, JS
    MURPHY, WK
    LIPPMAN, SM
    CALAYAG, M
    PANG, A
    CHASEN, M
    SHIN, DM
    GLISSON, B
    BENNER, S
    HUBER, M
    PEREZSOLER, R
    HONG, WK
    RABER, M
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1238 - 1244
  • [30] Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer
    Bryan J. Schneider
    Francis P. Worden
    Shirish M. Gadgeel
    Ralph E. Parchment
    Collette M. Hodges
    James Zwiebel
    Rodney L. Dunn
    Antoinette J. Wozniak
    Michael J. Kraut
    Gregory P. Kalemkerian
    Investigational New Drugs, 2009, 27 : 571 - 578
12345